The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
MedTAS Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
147 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VORICONAZOLE Mylan voriconazole 200mg Powder for Injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NORADRENALINE MYLAN noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL injection concentrated vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NORADRENALINE MYLAN noradrenaline (norepinephrine) (as acid tartrate monohydrate) 2 mg/2 mL injection concentrated vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESOMEPRAZOLE IV MYLAN esomeprazole 40 mg (as sodium) powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PANTOPRAZOLE IV ALPHAPHARM pantoprazole (as sodium sesquihydrate) 40 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PANTOPRAZOLE IV MYLAN pantoprazole (as sodium sesquihydrate) 40 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUOROURACIL ALPHAPHARM fluorouracil 1000 mg/20 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUOROURACIL MYLAN fluorouracil 5 g/100 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUOROURACIL AGILA fluorouracil 500 mg/10 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUOROURACIL MYLAN fluorouracil 2.5 g/50 mL solution for injection vial.